Switzerland: US Trade Talks Continue, No Retaliation in Works
Switzerland's government said it will continue negotiations in the hopes of avoiding 39% U.S. tariffs that begin Aug. 8, which it says will apply to 60% of its exports. Pharmaceuticals, a major product from Switzerland, are not subject to reciprocal tariffs.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
The Swiss government statement, issued Aug. 4, said that its government "remains in close contact with the affected sectors of the Swiss economy and with US officials."
"Through its contacts with the business community, the Federal Council has developed new approaches for its discussions with the United States and will continue negotiations with the aim of reaching a trade deal. Switzerland enters this new phase ready to present a more attractive offer, taking US concerns into account and seeking to ease the current tariff situation."
The statement said that Switzerland doesn't have industrial subsidies, and that 99% of U.S. exports enter its country duty-free. The Federal Council is not currently considering any countermeasures.